MedPAC > Our Work > Drugs, Devices, and Tests > MedPAC comment on CMS’s notice of proposed rulemaking entitled: Medicare Program: Payment Reform for Part B Drugs
MedPAC comment on CMS’s notice of proposed rulemaking entitled: Medicare Program: Payment Reform for Part B Drugs